News

Tagworks Pharmaceuticals has received two valorization grants, €180,000 total, from NanoNextNL, the Dutch research and innovation program on nanotechnology. The grants will be used to take two of the company's core programs to the next level. One grant concerns Tagworks' antibody drug conjugate (ADC) technology and will be applied to further …

For their proposal "Click chemistry-triggered activation of Antibody-Drug Conjugates", Tagworks Pharmaceuticals and the research group of professor Paul Yazaki at the Department of Immunology, City of Hope Beckman Research Institute in Duarte, CA, were awarded a US$465,000 Breakthrough Award through the Breast Cancer Research Program (BCRP) of the US Department …

13-17 March 2016, 251st ACS National Meeting & Exposition, San Diego, CA. Tagworks CEO Marc Robillard is an invited speaker in the "Design of Radioligands and Molecular Probes"-session on 14 March 2016. More information: acs.org/national meetings

9-13 November 2015, SPIRIT Summer School "Multimodal Molecular Imaging: from high resolution in vitro towards in vivo imaging" in Göttingen, Germany. On Thursday 12 November, Tagworks CEO Marc Robillard will instruct on 'Click Chemistry'.

7-10 December 2015, Antibody Engineering & Therapeutics, San Diego, CA. More information: ibclifesciences.com/AntibodyEng

22-24 February 2016, World ADC Frankfurt, Germany. More information: http://worldadc-europe.com

19-22 October 2015, World ADC San Diego, CA. More information: http://worldadc-usa.com

Two-day event on nanotechnology in Amersfoort, the Netherlands. More information: www.nanocity2015.com  

Tagworks' ceo Marc Robillard will present Tagworks' technology at the ADC Summit in London, May 18-19.

Tagworks' ceo Marc Robillard will present Tagworks' technology at the Spring symposium of the French Society for Medicinal Chemistry on 'Bioorthogonal Chemistry contributing to Molecular Therapeutic Innovation' in Paris.